Heme Malignancies I Flashcards
t(11:14)
Mantle cell lymphoma (Non-Hodgkin’s Lymphoma)
Which leukemia highly associated with DIC?
APL
“Core binding factor” leukemia and it’s associated cytogenetics
Acute myelomonocytic leukemia - inv(16:16)
Gingival hyperplasia
AML
Heart-shaped/bat wing nuclei?
APL
Arsenic MOA?
Breaks down PML-RARalpha fusion protein
BBW for Arsenic?
CV - QT prolongation, AV block, etc
CD14+/CD11b+
Acute myelomonocytic leukemia
Definition of class I hypothesis
Fusion gene causes constitutively active pro-proliferation gene
Definition of class II hypothesis
Fusion gene acts as a corepressor, inhibiting differentiation
AML translocations fit under class ___ hypothesis
II (inhibits differentiation of myelocytes)
AML associated with eosinophilia?
Acute myelomonocytic leukemia
Epidemiology of hairy cell leukemia?
Middle aged (~40yo) male
Most common cutaneous lymphoma and its cell?
Mycoses fungoides - Sezary cell
Which AML does NOT have CD34+ immunophenotype?
APL
Which method used to asses immunophenotype?
Flow cytometry
First step in workup of any heme disease
PBS
Five criteria to classify something as a blast
- Big cell 2. Increased cytoplasm:nuclear ratio 3. Immature chromatin 4. Large nucleus (may be >1 nucleus) 5. Bunch of cells that look alike
3 steps in bone marrow aspiration
- Half cc of bloody aspirate 2. 5-20 cc in same spot for special studies 3. Core biopsy from different site
Purpose of core biopsy in new spot
Will not contain blood if you draw from same site where aspirate was done
Normal range of myeloid:erythroid precurors
2:1 - 5:1 (myeloid should always outnumber erythroid precursors)
How to estimate cellularity of bone marrow
100-age (rest is fat)
Hapten
Site where an antigen binds (so a CD is a hapten)
Flow is a weak method for detecting ____ cells. Why?
Erythroid precursors - they’re lysed before flow so they’re underrepresented on scatter plots
Side scatter measures ____; front scatter measures _____.
Side scatter measures complexity (granules, seg nuclei); front scatter measures size.
On flow scatter plot, x-axis is generally ___, while y-axis is ____.
X-axis = CD45 (on almost all stem cells in different concentrations) Y-axis - SSC
Two immunophenotypes associated with AML’s
CD33+(marker for granulocytes)/CD34+(marker for HSC) = myeloid blasts! **Remember: APL NOT assc. with CD34
Reed-Sternberg/”owl eyes” cells
HL
CD15+/CD30+
RS cell = HL
t(9:22) causes what fusion protein?
BCR/ABL in CML
MOA of ATRA
Drives differentiation of blasts; tx for PML
In which stage of cell cycle must cells be for karyotyping? FISH?
Karyotyping = metaphase FISH = interphase
Red probe hybridized to chr9; green probe to chr22. What would CML look like on this FISH?
Yellow (t9:22)
Acute leukemias vs. myeloproliferative disorders
Acute leukemias = RAPIDLY proliferating BLASTS Myeloproliferative = CHRONICALLY proliferating DIFFERENTIATED blood cells
Which lineages can be involved in acute leukemias?
Myeloid, erthyroid, megakaryocyte
What is a myeloid sarcoma?
Acute myeloid LEUKEMIA with monocyte-like features that presents as solid tumors in bone or connective tissue (blasts outside marrow)
CD10/CD19 found on:
Lymphoid blasts
(T/F): Immunophenotype strongly correlated with response to tx.
False
(T/F): Genetics strongly correlated with response to tx.
True
Runx1-Runx1T1 is class I or II mutation?
II (AML t8:21)
FLT3-ITD is class I or II mutation?
!
Inv(16) results in what fusion protein?
CBFB-MYH11 *remember: acute myelomonocytic leukemia is core binding factor leukemia
(T/F): Dominant negative t8:21 sufficient to cause AML
False. Must have class I mutation, too.
Leukemia associated with thrombocytopenia?
APL (DIC!!!!)
AML prognosis: NPM1 + or CEBPA + and FLT3-ITD -
Poor; HSCT doesn’t help
AML prognosis: FLT3-ITD+
Good; HSCT helps
AML prognosis: NPM1 - and CEBPA - and FLT3-ITD -
Good; HSCT helps
How could one immunophenotypically tell apart the B cell ALLs?
t(9:22) = has CD10/19 and TdT t(11:19) = MISSING CD10 t(12:21) = CD34+
Imatinib could be used for which of the ALLs?
B cell ALL t(9:22); confers tyrosine kinase activity (class I mutation)
Most common ALL in very young pts?
t(11:19)
Fusion protein of B cell ALL t(11:19)? Prognosis?
MLL (histone methyltransferase = class II) Bad
Gilliand hypothesis doesn’t support which ALL?
B-ALL t(12:21)
Pax5 mutation seen in which ALL?
B-ALL t(12;21)
TRAP stain
Hairy cell leukemia (B-ALL)
Only leukemia w/o lymphadenopathy
Hairy cell (B-ALL)
Fusion gene of hairy cell leukemia
BRAF-V600
Rituximab is tx for which leukemia
Hairy cell (CD20+)
IFN2-a,b used for:
Hairy cell leukemia (B-ALL)
Dry bone marrow
Hairy cell leukemia (B-ALL)
Thymic mass + lymphadenopathy + splenomegaly
T-ALL
CD3+
T-ALL
Genetic abnormality of T-ALL
Translocation of oncogene to Ig or TCR promoter of chromosome 14
Morphology of every ALL (except hairy cell)
Big agranular blasts
WHO classification of AML
Blasts > 20%
(T/F): CD13/34 only found in myelogenous malignancies.
False - lymphoid malignancies may also express myeloid markers.
75% of ALL presents in pts < ____ yo
6
Class II mutation in B-ALL t(9:22)
IKZF1
t(9:22) in B-ALL vs. CML
B-ALL = p190 CML = p210 *Gene cleaved at different sites
Prognosis B-ALL t(9:22)
BAD
t(9:22) more common in adult or pediatric ALL?
20% adult ALL; 2-4% of pediatric ALL
Most common leukemia in kids <1 yo
B-ALL t(11:19)
B-ALL with class I mutation?
t(9:22); others are class II
Prognosis B-ALL t(12;21)
Good! ~90% cure rate!
Pax5 deletion (B-ALL t9:22) is a class ___ mutation.
II
Adolescent male with mediastinal mass:
T-ALL (thymic mass!!)
Relapse of ALL often presents in:
CNS and testis
Appearance of granules in lymphocytic leukemias:
ABSENT (agranular cells)
Most responsive leukemia to tx?
ALL
PML = M___
3
85% of MALTs associated with:
H. pylori